These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 34111698)
1. Generation of an induced pluripotent stem cell line HPCASRi002-A from a patient with neonatal severe primary hyperparathyroidism caused by a compound heterozygous mutation in the CASR gene. Panova AV; Kulikova KS; Klementieva NV; Krylov ID; Snezhko IO; Tiulpakov AN; Kiselev SL Stem Cell Res; 2021 Jul; 54():102414. PubMed ID: 34111698 [TBL] [Abstract][Full Text] [Related]
2. A novel CASR mutation associated with neonatal severe hyperparathyroidism transmitted as an autosomal recessive disorder. Diaz-Thomas A; Cannon J; Iyer P; Al-Maawali A; Fazalullah M; Diamond F; Mueller OT; Root AW; Alyaarubi S J Pediatr Endocrinol Metab; 2014 Sep; 27(9-10):851-6. PubMed ID: 24854525 [TBL] [Abstract][Full Text] [Related]
3. Subtotal Parathyroidectomy Successfully Controls Calcium Levels of Patients with Neonatal Severe Hyperparathyroidism Carrying a Novel CASR Mutation. Wejaphikul K; Dejkhamron P; Khorana J; Watcharachan K; Intachai W; Olsen B; Tongsima S; Ketudat Cairns JR; Ngamphiw C; Kantaputra P Horm Res Paediatr; 2023; 96(4):432-438. PubMed ID: 36626889 [TBL] [Abstract][Full Text] [Related]
4. Neonatal Severe Hyperparathyroidism: Novel Insights From Calcium, PTH, and the CASR Gene. Marx SJ; Sinaii N J Clin Endocrinol Metab; 2020 Apr; 105(4):1061-78. PubMed ID: 31778168 [TBL] [Abstract][Full Text] [Related]
5. Cinacalcet as a First-Line Treatment in Neonatal Severe Hyperparathyroidism Secondary to Calcium Sensing Receptor (CaSR) Mutation. Gulcan-Kersin S; Kirkgoz T; Eltan M; Rzayev T; Ata P; Bilgen H; Ozek E; Bereket A; Turan S Horm Res Paediatr; 2020; 93(5):313-321. PubMed ID: 33147586 [TBL] [Abstract][Full Text] [Related]
6. New mutation in the CASR gene in a family with familial hypocalciuric hypercalcemia (FHH) and neonatal severe hyperparathyroidism (NSHPT). Rodrigues LS; Cáu AC; Bussmann LZ; Bastida G; Brunetto OH; Corrêa PH; Martin RM Arq Bras Endocrinol Metabol; 2011 Feb; 55(1):67-71. PubMed ID: 21468522 [TBL] [Abstract][Full Text] [Related]
7. Case report: acute clinical presentation and neonatal management of primary hyperparathyroidism due to a novel CaSR mutation. Capozza M; Chinellato I; Guarnieri V; Di Lorgi N; Accadia M; Traggiai C; Mattioli G; Di Mauro A; Laforgia N BMC Pediatr; 2018 Oct; 18(1):340. PubMed ID: 30376845 [TBL] [Abstract][Full Text] [Related]
8. Calcium signaling regulates trafficking of familial hypocalciuric hypercalcemia (FHH) mutants of the calcium sensing receptor. Grant MP; Stepanchick A; Breitwieser GE Mol Endocrinol; 2012 Dec; 26(12):2081-91. PubMed ID: 23077345 [TBL] [Abstract][Full Text] [Related]
9. Mutations of the calcium-sensing receptor (CASR) in familial hypocalciuric hypercalcemia, neonatal severe hyperparathyroidism, and autosomal dominant hypocalcemia. Hendy GN; D'Souza-Li L; Yang B; Canaff L; Cole DE Hum Mutat; 2000 Oct; 16(4):281-96. PubMed ID: 11013439 [TBL] [Abstract][Full Text] [Related]
10. Neonatal severe hyperparathyroidism caused by homozygous mutation in CASR: A rare cause of life-threatening hypercalcemia. Murphy H; Patrick J; Báez-Irizarry E; Lacassie Y; Gómez R; Vargas A; Barkemeyer B; Kanotra S; Zambrano RM Eur J Med Genet; 2016 Apr; 59(4):227-31. PubMed ID: 26855056 [TBL] [Abstract][Full Text] [Related]
11. Cinacalcet monotherapy in neonatal severe hyperparathyroidism: a case study and review. Gannon AW; Monk HM; Levine MA J Clin Endocrinol Metab; 2014 Jan; 99(1):7-11. PubMed ID: 24203066 [TBL] [Abstract][Full Text] [Related]
12. Novel homozygous inactivating mutation of the calcium-sensing receptor gene in neonatal severe hyperparathyroidism responding to cinacalcet therapy: A case report and literature review. Sun X; Huang L; Wu J; Tao Y; Yang F Medicine (Baltimore); 2018 Nov; 97(45):e13128. PubMed ID: 30407334 [TBL] [Abstract][Full Text] [Related]
14. Neonatal severe hyperparathyroidism: further clinical and molecular delineation. Al-Khalaf FA; Ismail A; Soliman AT; Cole DE; Ben-Omran T Eur J Pediatr; 2011 May; 170(5):625-31. PubMed ID: 20972686 [TBL] [Abstract][Full Text] [Related]
15. [Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism caused by inactivating mutations of calcium-sensing receptor]. Watanabe S; Fukumoto S Nihon Rinsho; 2002 Feb; 60(2):325-30. PubMed ID: 11857921 [TBL] [Abstract][Full Text] [Related]
16. Neonatal severe hyperparathyroidism associated with a novel de novo heterozygous R551K inactivating mutation and a heterozygous A986S polymorphism of the calcium-sensing receptor gene. Tõke J; Czirják G; Patócs A; Enyedi B; Gergics P; Csákváry V; Enyedi P; Tóth M Clin Endocrinol (Oxf); 2007 Sep; 67(3):385-92. PubMed ID: 17555508 [TBL] [Abstract][Full Text] [Related]
18. A homozygous inactivating calcium-sensing receptor mutation, Pro339Thr, is associated with isolated primary hyperparathyroidism: correlation between location of mutations and severity of hypercalcaemia. Hannan FM; Nesbit MA; Christie PT; Lissens W; Van der Schueren B; Bex M; Bouillon R; Thakker RV Clin Endocrinol (Oxf); 2010 Dec; 73(6):715-22. PubMed ID: 20846291 [TBL] [Abstract][Full Text] [Related]
19. The efficiency of cinacalcet treatment in delaying parathyroidectomy in a case with neonatal severe hyperparathyroidism caused by homozygous mutation in the CASR gene. Özgüç Çömlek F; Demir S; Gürkan H; İnan M; Sezer A; Dilek E; Kökenli F Pediatr Endocrinol Diabetes Metab; 2022; 28(2):168-174. PubMed ID: 35399047 [TBL] [Abstract][Full Text] [Related]
20. Reduced affinity of calcium sensing-receptor heterodimers and reduced mutant homodimer trafficking combine to impair function in a model of familial hypocalciuric hypercalcemia type 1. Wang X; Lundblad J; Smith SM PLoS One; 2022; 17(7):e0266993. PubMed ID: 35857775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]